Brief: BenevolentAI Signs Strategic Collaboration With Merck

BenevolentAI SA

20/09/2023 06:07

Sept 20 (Reuters) - BenevolentAI SA  BAI.AS :
    * BENEVOLENTAI SIGNS STRATEGIC COLLABORATION WITH MERCK
    * COLLABORATION UTILISES BENEVOLENTAI'S END-TO-END AI
PLATFORM
CAPABILITIES TO DELIVER NOVEL DRUG CANDIDATES, INITIALLY FOR
THREE TARGETS IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY
    * TO IDENTIFY AND DEVELOP INNOVATIVE COMPOUNDS THROUGH HIT
IDENTIFICATION TO PRE-CLINICAL STAGE
    * AGREEMENT INCLUDES PAYMENTS TO BENEVOLENTAI OF UP TO $594
MILLION
    * TIERED ROYALTIES WILL ALSO BE PAYABLE ON NET SALES OF ANY
COMMERCIALISED PRODUCTS

Source text for Eikon:  ID:nBw5Z62MLa 
Further company coverage:  BAI.AS 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))